(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FUCASO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FUCASO

ST13

US500000079360485

Class

5, 35, 42, 44

Filing

79360485

Registration

7227099

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

01/21/2024

Trademark type

Word

Nice classes

5, 35, 42, 44

Filing date

10/20/2022

Registration date

11/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/28/2023

Last transaction

11/28/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CN

Examiner

BLAZICH,JOAN MICHELE

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Nanjing IASO Medical Technology Co., Ltd.

Representatives

Unitalen Attorneys At Law

Technical classification

Nice Classes

Class 5Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; cytostatics for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; diagnostic preparations for medical purposes; biological preparations for the treatment of immune system related disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in chemotherapy; biological preparations for the treatment of tumor; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; diagnostic biomarker reagents for medical purposes

Class 35

Advertising services; assistance in franchised commercial business management; import-export agency services; sales promotion for others; retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; retail drug store services

Class 42

Technological research in the field of medicine; technical research in the field of pharmaceutical studies; research and development of new products for others; scientific laboratory services; medical laboratory services; pharmaceutical research services; biomedical research services; research and development services in the field of antibodies; pharmaceutical research and development; biotechnology research; research on the subject of pharmaceuticals

Class 44

Performing diagnosis of diseases; medication counseling; medical consultations; consulting services in the field of health; medical services; providing cancer screening services; genetic testing for medical purposes; medical analysis for the diagnosis and treatment of persons; medical services relating to the removaltreatment and processing of human blood

Publications

History of USPTO decisions and trademark events.

16 publications found

GPNX

NOTIFICATION PROCESSED BY IB

01/21/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/04/2024

FIMP

FINAL DISPOSITION PROCESSED

01/04/2024

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

12/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/28/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/18/2023

PUBO

PUBLISHED FOR OPPOSITION

09/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/30/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/30/2023

NPUB

NOTICE OF PUBLICATION

08/23/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2023

DOCK

ASSIGNED TO EXAMINER

08/04/2023

MAFR

APPLICATION FILING RECEIPT MAILED

02/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/28/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/23/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/19/2023

Continuous trademark protection

Get notified about every new filing that threatens FUCASO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.